Impact of treatment effect on MRD and PFS: an aggregate data analysis from randomized clinical trials in multiple myeloma

被引：13
|
作者：
Paiva, Bruno [6 ]
Zherniakova, Anastasiia
Nunez-Cordoba, Jorge M.
Rodriguez-Otero, Paula
Shi, Qian [1 ]
Munshi, Nikhil C. [2 ]
Durie, Brian G. M. [3 ,4 ,5 ]
San-Miguel, Jesus
机构：
[1] Univ Navarra, Canc Ctr Clin, Sinai Med Ctr CB16, Ctr Invest Med Aplicada,Inst Invest Sanitaria Nava, Pamplona 00369, Spain
[2] Mayo Clin, Dept Quantitat Hlth Sci, Rochester, MN USA
[3] Dana Farber Canc Inst, Boston, MA USA
[4] Boston VA Healthcare Syst, Boston, MA USA
[5] Cedars Sinai Med Ctr, Los Angeles, CA USA
[6] Clin Univ Navarra, Ctr Invest Med Aplicada, Ctr Invest Biomed Red Canc, Inst Invest Sanitaria Navarra, Pamplona 31008, Spain
来源：
BLOOD ADVANCES | 2024年 / 8卷 / 01期
关键词：
OPEN-LABEL; DEXAMETHASONE; BORTEZOMIB; LENALIDOMIDE; CARFILZOMIB; DARATUMUMAB; SURVIVAL; TRANSPLANTATION; MULTICENTER; OUTCOMES;
D O I：
10.1182/bloodadvances.2023010821
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：219 / 223
页数：5
相关论文
共 50 条
  • [1] Impact of treatment effect on measurable residual disease (MRD) and progression-free survival (PFS): an aggregate data analysis from randomized clinical trials in multiple myeloma (MM)
    Paiva, Bruno
    Zherniakova, Anastasiia
    Nunez, Jorge
    Rodriguez-Otero, Paula
    Shi, Qian
    Munshi, Nikhil
    Durie, Brian
    San-Miguel, Jesus
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S78 - S78
  • [2] Efficacy of Carfilzomib in the Treatment of Relapsed and (or) Refractory Multiple Myeloma: a Meta-analysis of Data from Clinical Trials
    Chen, Runzhe
    Chen, Baoan
    Zhang, Xiaoping
    Gao, Chong
    DISCOVERY MEDICINE, 2016, 22 (121) : 189 - 199
  • [3] An Investigation of Potential Treatment Effect Modifiers in Multiple Myeloma from Published Randomized Controlled Trials
    He, Jianming
    Chiang, Karen
    Lin, Xiwu
    Maringwa, John
    Yang, Lingfeng
    Kwong, Jackie
    Nair, Sandhya
    Hashim, Mahmoud
    Samjoo, Imtiaz
    BLOOD, 2024, 144 : 7827 - 7828
  • [4] Efficacy of Carfilzomib in the Treatment of Relapsed and (or) Refractory Multiple myeloma: a Meta Analysis of Individual Patient Data from Clinical Trials
    Chen, Runzhe
    Chen, Baoan
    Ge, Zheng
    BLOOD, 2016, 128 (22)
  • [5] Is Anticonvulsant Treatment of Mania a Class Effect? Data from Randomized Clinical Trials
    Rosa, A. R.
    Fountoulakis, K.
    Siamouli, M.
    Gonda, X.
    Vieta, E.
    CNS NEUROSCIENCE & THERAPEUTICS, 2011, 17 (03) : 167 - 177
  • [6] Addition of Elotuzumab to Backbone Treatment Regimens for Multiple Myeloma: An Updated Meta-Analysis of Randomized Clinical Trials
    Costa, Bruno Almeida
    Costa, Thomaz Alexandre
    Chagas, Gabriel Cavalcante Lima
    Mouhieddine, Tarek H.
    Richter, Joshua
    Usmani, Saad Z.
    Mailankody, Sham
    Rajeeve, Sridevi
    Hashmi, Hamza
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2025, 25 (01): : 32 - 44
  • [7] Minimal Residual Disease-Based End Point for Accelerated Assessment of Clinical Trials in Multiple Myeloma: A Pooled Analysis of Individual Patient Data From Multiple Randomized Trials
    Shi, Qian
    Paiva, Bruno
    Pederson, Levi D.
    Dimier, Natalie
    Talpes, Ela
    Prior, Thomas J.
    Orfao, Alberto
    Moreau, Philippe
    Sonneveld, Pieter
    Kumar, Shaji K.
    Dixon, Jesse G.
    Patel, Reshma
    Bartlett, Blake J.
    Schecter, Jordan
    McCarthy, Phillip
    Hose, Dirk
    Seckinger, Anja
    Mattia, D'Agostino
    Goldschmidt, Hartmut
    Oliva, Stefania
    Owen, Roger G.
    Anderson, Kenneth C.
    San-Miguel, Jesus
    Durie, Brian G. M.
    Munshi, Nikhil
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (11)
  • [8] Adverse Event Reporting in Randomized Clinical Trials for Multiple Myeloma
    Najjar, Mimi
    McCarron, John
    Cliff, Edward R. Scheffer
    Berger, Katherine
    Steensma, David P.
    Al Hadidi, Samer
    Chakraborty, Rajshekhar
    Goodman, Aaron
    Anto, Eric
    Greene, Tom
    Sborov, Douglas
    Mohyuddin, Ghulam Rehman
    JAMA NETWORK OPEN, 2023, 6 (11) : E2342195
  • [9] Addition of Daratumumab to Drug Regimens in the Treatment of Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
    Aiman, Wajeeha
    Anwar, Ayesha
    Satti, Danish Iltaf
    Hamza, Mohammad
    Perez, Alynna Mariz
    Khan, Arslan Ahmad
    Nepal, Ashish
    Supraja, A.
    Yeesau, Mariam
    Nanjundaiah, Nikhilesh
    Kaleem, Muhammad Shaarif
    Avula, Sreekant
    Dewan, Sandesh
    Kosach, Sviatoslav
    Tarrar, Talha Azam
    Suleman, Muhammad
    Ali, Muhammad Ashar
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S405 - S405
  • [10] Application of Multiple Imputation in Analysis of Data from Clinical Trials with Treatment Related Dropouts
    Liu, Rong
    Ramakrishnan, Viswanathan
    COMMUNICATIONS IN STATISTICS-THEORY AND METHODS, 2009, 38 (20) : 3666 - 3677
12345